Target intelligence / Profile preview

Centrosomal protein 95 (CEP95)

Target
CEP95
Molecular classification
Other (centrosomal structural protein)
01

Overview

Centrosomal protein 95 (CEP95) is a coiled-coil domain–containing protein localized at the centrosome and spindle poles, essential for proper centrosome organization and function during cell division[1][3][5]. It is implicated in diverse biological processes, including tumor progression (serving as a potential hub gene in cancer co-expression networks, notably in lung adenocarcinoma), regulation of telomere length (in pathways affecting cellular aging), and human growth regulation (identified in genetic studies associated with height)[1]. While CEP95 is not an established therapeutic drug target, its altered expression or mutation has been linked to multiple disease phenotypes and cellular processes. Key points: - CEP95 is a centrosomal structural protein, not functioning as a receptor, enzyme, or transporter[1][5]. - It serves housekeeping roles in centrosome-associated processes and is emerging for its potential significance in oncology and genetics[1]. - There are currently no drugs known to directly target CEP95, and no formal safety concerns or mechanisms of action for therapeutic intervention are established. Note: CEP95 is not a receptor, enzyme, or transporter, and is not currently considered a direct therapeutic target, although its roles in cancer and cell cycle regulation make it of significant research interest[1][5].

Other names
Centrosomal protein of 95 kDaCEP95CCDC45CEP45DKFZp667E1824Coiled-coil domain-containing protein 45centrosomal protein 95 kDacoiled-coil domain containing 45
02

Biological functions

Centrosome organizationspindle pole formationcell cycle regulation
03

Disease associations

Cancer (implicated in cancer progression, e.g. lung adenocarcinoma)Cellular aging/telomere biologyGrowth regulation (genetic control of human growth/height)
04

Biomarkers

Potential tissue and tumor biomarker (expression associated with tumor progression in cancers such as lung adenocarcinoma)

Beyond the preview

Go deeper on Centrosomal protein 95 (CEP95).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centrosomal protein 95 (CEP95).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call